Blythedale names new medical chief
Blythedale Children”™s Hospital in Valhalla has named Dr. Scott M. Klein its new chief medical officer and chief of pediatrics.
Klein will replace Dr. Joelle Mast, who will become Blythedale”™s chief science officer, responsible for expanding the hospital”™s research program.
Blythedale President and CEO Larry Levine made the announcement.
Klein, 43, of Roslyn, Long Island, comes to Blythedale with 10 years of experience at Maimonides Infants and Children”™s Hospital in Brooklyn, where he served as vice chairman of clinical services, associate medical director and director of the pediatric critical care unit. For the past two years, he served as CMO for hospice and palliative care at the Visiting Nurse Service of New York.
“Blythedale is at a very exciting point in its history, and we are thrilled to welcome Scott Klein on board,” said Levine. “Dr. Klein brings a unique skill set and understanding of the delivery of pediatric specialty care that will enable us to set the standard for how care is delivered to medically fragile children.”
Blythedale opened its $65.3 million, 86-bed, 56,000-square-foot inpatient building in December 2011. Its services include an infant, toddler and post-neonatal and pediatric intensive care unit, a dedicated traumatic brain injury unit, a pediatric and adolescent inpatient unit and family resource center.
Klein is board certified in pediatrics, pediatric critical care medicine and pediatric hospice and palliative care medicine.
“The children we care for at Blythedale are the most medically fragile patients ”“ children with severe respiratory conditions, congenital heart ailments, traumatic brain injuries, severe burns and a host of other injuries or illnesses,” Klein said. “It is our responsibility to deliver the highest levels of quality healthcare and medical rehabilitation services to help them recover as best and as quickly as possible and look forward to the lives ahead of them.”
“Dr. Mast has played a vital role in Blythedale”™s growth over the last two decades,” said Levine. “As we continue to expand our research capabilities, we are very fortunate that she will be leading our research team and overseeing projects that can have a tremendous impact on the lives of medically fragile children.”